Carboplatin bulk supplier for pharma manufacturers

Carboplatin Suppliers & Bulk Manufacturers

Available Forms: Injection

Available Strengths: 50 mg/5 mL , 150 mg/15 mL, 450 mg/45 mL

Reference Brands: Paraplatin® (EU & US)

Carboplatin is an intravenous chemotherapy used for ovarian, lung, head and neck, and testicular cancer. Available in 50 mg/5 mL, 150 mg/15 mL, and 450 mg/45 mL injections in the US and EU.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Carboplatin? List it or send an offer →

Product Description: Carboplatin, marketed as Paraplatin®, is a platinum-based chemotherapy agent used in the treatment of various cancers, including ovarian, lung, head and neck, testicular, and bladder cancer. It is administered intravenously in 50 mg/5 mL, 150 mg/15 mL, and 450 mg/45 mL formulations. Carboplatin interferes with the DNA of cancer cells, preventing their division and growth. Manufactured under stringent GMP regulations, it offers key opportunities for B2B oncology pharmaceutical companies targeting hospitals, oncology clinics, and cancer treatment centers in the US and EU markets.

Carboplatin — third party manufacturing & bulk supply

Carboplatin is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Carboplatin is supplied as Injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Carboplatin listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Carboplatin →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

Carboplatin is listed as Injection in 50 mg/5 mL , 150 mg/15 mL, 450 mg/45 mL. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Carboplatin is referenced against Paraplatin® (EU & US). Reference brands are shown for identification only and remain the property of their respective trademark owners.